Bavarian Nordic to buy GSK’s rabies and tick-borne encephalitis vaccines

Bavarian Nordic to buy GSK’s rabies and tick-borne encephalitis vaccines

Source: 
Pharmaceutical Business Review
snippet: 


Denmark-based Bavarian Nordic has signed an agreement to acquire rabies and tick-borne encephalitis (TBE) vaccines from GlaxoSmithKline in a deal valued at around €796m ($888m).